Hemenway Trust Co LLC Buys 7,726 Shares of Danaher Corporation (NYSE:DHR)

Hemenway Trust Co LLC lifted its stake in Danaher Corporation (NYSE:DHR - Free Report) by 4.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 168,909 shares of the conglomerate's stock after acquiring an additional 7,726 shares during the period. Danaher makes up about 2.8% of Hemenway Trust Co LLC's holdings, making the stock its 15th largest holding. Hemenway Trust Co LLC's holdings in Danaher were worth $34,626,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Heck Capital Advisors LLC bought a new position in shares of Danaher in the fourth quarter worth $27,000. Hurley Capital LLC bought a new position in shares of Danaher in the fourth quarter worth $34,000. Rialto Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter worth $34,000. Rakuten Securities Inc. boosted its holdings in shares of Danaher by 380.0% in the fourth quarter. Rakuten Securities Inc. now owns 168 shares of the conglomerate's stock worth $39,000 after acquiring an additional 133 shares during the period. Finally, Ameriflex Group Inc. bought a new position in shares of Danaher in the fourth quarter worth $38,000. 79.05% of the stock is owned by institutional investors.

Danaher Trading Down 2.6%

NYSE DHR opened at $195.81 on Wednesday. The stock's 50-day simple moving average is $193.42 and its two-hundred day simple moving average is $210.43. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $140.13 billion, a price-to-earnings ratio of 38.02, a PEG ratio of 2.82 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The business had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Research analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher's dividend payout ratio is currently 24.85%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DHR. Citigroup reaffirmed a "buy" rating on shares of Danaher in a report on Monday, April 7th. The Goldman Sachs Group dropped their price objective on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Guggenheim reissued a "buy" rating and set a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Wolfe Research dropped their price objective on Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research note on Monday, April 7th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Five research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $248.17.

Insider Transactions at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.